TY - JOUR
T1 - Fasting Serum IGFBP-1 as a Marker of Insulin Resistance in Diverse School Age Groups
AU - Bhangoo, Amrit
AU - Gupta, Rishi
AU - Shelov, Steve P.
AU - Carey, Dennis E.
AU - Accacha, Siham
AU - Fennoy, Ilene
AU - Altshuler, Lisa
AU - Lowell, Barbara
AU - Rapaport, Robert
AU - Rosenfeld, Warren
AU - Speiser, Phyllis W.
AU - Ten, Svetlana
AU - Rosenbaum, Michael
N1 - Funding Information:
We gratefully acknowledge the Department of Health and Department of Education of New York City, as well as Drs. Henry Solomon and Roger Platt. We also thank the local school boards, school principals, teachers, faculty, and students at all participating schools. The development of this pilot project was supported by AMDeC, the Naomi Berrie Diabetes Research Center, the Columbia Diabetes and Endocrinology Research Center (DERC). We would also like to acknowledge Robert Levine, Michelle Klein, Abeer Hassoun, Rushika Conroy, F. Jean-Jacques, Deborah DeSantis, Amy Jean, and Lesly Michel.
Funding Information:
We gratefully acknowledge the Department of Health and Department of Education of New York City, as well as Drs. Henry Solomon and Roger Platt. We also thank the local school boards, school principals, teachers, faculty, and students at all participating schools. The development of this pilot project was supported by AMDeC, the Naomi Berrie Diabetes Research Center, the Columbia Diabetes and Endocrinology Research Center (DERC). We would also like to acknowledge Robert Levine, Michelle Klein, Abeer Hassoun, Rushika Conroy, F. Jean-Jacques, Deborah DeSantis, Amy Jean, and Lesly Michel.
Funding Information:
The study was supported by AMDeC, the Starr Foundation, and NIH grant numbers UL1RR0023568 and UL1RR0024156.
Publisher Copyright:
Copyright © 2022 Bhangoo, Gupta, Shelov, Carey, Accacha, Fennoy, Altshuler, Lowell, Rapaport, Rosenfeld, Speiser, Ten and Rosenbaum.
PY - 2022/5/2
Y1 - 2022/5/2
N2 - Introduction: The known markers of insulin resistance in obese children are well studied. However, they require serial measurements and complicated calculations. The objective is to study IGFBP-1 and its relation with other known risk measures. Materials and Methods: The study included 98 New York City school students of diverse ethnic/racial backgrounds (57 males and 41 females), 11–15 years of age. Subjects were enrolled in a cross-sectional study, and anthropometric measures were collected. They underwent fasting intravenous glucose tolerance tests (IVGTT), and glucose, insulin, lipids, IGFBP-1, adiponectin and inflammatory markers were collected. Results: The subjects were stratified into 3 groups based upon the BMI Z-score. Out of all the subjects, 65.3% were in the group with a BMI Z-score <1 SDS, 16.3% subjects were in the group with a BMI Z-score of 1 to 2 SDS, and 18.4% of the subjects were in the group with a BMI Z-score of more than 2 SDS. The group with a BMI Z-score of more than 2 SDS had increased waist circumference (WC), body fat, increased fasting insulin, and triglycerides (TG). This group had decreased levels of adiponectin and HDL and low IGFBP-1 as compared to the group with BMI <1 SDS. The group with a BMI Z-score of 1 to 2 SDS had a decreased level of IGFBP-1 as compared to the group with a BMI Z-score less than 1 SDS. IGFBP-1 inversely correlated with age, WC, BMI, body fat, TG, and insulin levels. IGFBP-1 positively correlated with adiponectin and HDL levels. Conclusion: IGFBP-1 in children can identify the presence of insulin resistance in the group with BMI 1 to 2 SDS, even before the known markers of insulin resistance such as elevated triglycerides and even before decreased HDL and adiponectin levels are identified.
AB - Introduction: The known markers of insulin resistance in obese children are well studied. However, they require serial measurements and complicated calculations. The objective is to study IGFBP-1 and its relation with other known risk measures. Materials and Methods: The study included 98 New York City school students of diverse ethnic/racial backgrounds (57 males and 41 females), 11–15 years of age. Subjects were enrolled in a cross-sectional study, and anthropometric measures were collected. They underwent fasting intravenous glucose tolerance tests (IVGTT), and glucose, insulin, lipids, IGFBP-1, adiponectin and inflammatory markers were collected. Results: The subjects were stratified into 3 groups based upon the BMI Z-score. Out of all the subjects, 65.3% were in the group with a BMI Z-score <1 SDS, 16.3% subjects were in the group with a BMI Z-score of 1 to 2 SDS, and 18.4% of the subjects were in the group with a BMI Z-score of more than 2 SDS. The group with a BMI Z-score of more than 2 SDS had increased waist circumference (WC), body fat, increased fasting insulin, and triglycerides (TG). This group had decreased levels of adiponectin and HDL and low IGFBP-1 as compared to the group with BMI <1 SDS. The group with a BMI Z-score of 1 to 2 SDS had a decreased level of IGFBP-1 as compared to the group with a BMI Z-score less than 1 SDS. IGFBP-1 inversely correlated with age, WC, BMI, body fat, TG, and insulin levels. IGFBP-1 positively correlated with adiponectin and HDL levels. Conclusion: IGFBP-1 in children can identify the presence of insulin resistance in the group with BMI 1 to 2 SDS, even before the known markers of insulin resistance such as elevated triglycerides and even before decreased HDL and adiponectin levels are identified.
KW - BMI – body mass index
KW - IGFBP-1
KW - adiposity
KW - insulin resistance
KW - waist circumference
UR - http://www.scopus.com/inward/record.url?scp=85130220010&partnerID=8YFLogxK
U2 - 10.3389/fendo.2022.840361
DO - 10.3389/fendo.2022.840361
M3 - Article
AN - SCOPUS:85130220010
VL - 13
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
SN - 1664-2392
M1 - 840361
ER -